Medical management of Crohn’s disease: state of the art and future perspectives
Over the past decade, the improvement in the understanding of the molecular mechanisms of Crohn’s disease (CD) led to the development of more targeted therapies, including biologics - i.e. monoclonal antibodies that selectively block key mediators of inflammation - and novel small molecule drugs -...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-09-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | https://www.italjmed.org/index.php/ijm/article/view/1194 |